![EP3805243A1 - Androstane derivatives with activity as pure or predominantly pure stimulators of serca2a for the treatment of heart failure - Google Patents EP3805243A1 - Androstane derivatives with activity as pure or predominantly pure stimulators of serca2a for the treatment of heart failure - Google Patents](https://patentimages.storage.googleapis.com/8a/0e/a4/43a85d544cb17c/imgb0037.png)
EP3805243A1 - Androstane derivatives with activity as pure or predominantly pure stimulators of serca2a for the treatment of heart failure - Google Patents
![EP3805243A1 - Androstane derivatives with activity as pure or predominantly pure stimulators of serca2a for the treatment of heart failure - Google Patents EP3805243A1 - Androstane derivatives with activity as pure or predominantly pure stimulators of serca2a for the treatment of heart failure - Google Patents](https://patentimages.storage.googleapis.com/d6/27/23/fe3803f9cd253b/imgb0047.png)
EP3805243A1 - Androstane derivatives with activity as pure or predominantly pure stimulators of serca2a for the treatment of heart failure - Google Patents
![EP3805243A1 - Androstane derivatives with activity as pure or predominantly pure stimulators of serca2a for the treatment of heart failure - Google Patents EP3805243A1 - Androstane derivatives with activity as pure or predominantly pure stimulators of serca2a for the treatment of heart failure - Google Patents](https://patentimages.storage.googleapis.com/d9/d9/de/7786c96fb606fa/imgb0077.png)
EP3805243A1 - Androstane derivatives with activity as pure or predominantly pure stimulators of serca2a for the treatment of heart failure - Google Patents
![EP3805243A1 - Androstane derivatives with activity as pure or predominantly pure stimulators of serca2a for the treatment of heart failure - Google Patents EP3805243A1 - Androstane derivatives with activity as pure or predominantly pure stimulators of serca2a for the treatment of heart failure - Google Patents](https://patentimages.storage.googleapis.com/77/78/48/1524ecebe18e64/imgb0001.png)
EP3805243A1 - Androstane derivatives with activity as pure or predominantly pure stimulators of serca2a for the treatment of heart failure - Google Patents
![Chapter 29. A Macro Stress Test Model of Credit Risk for the Brazilian Banking Sector in: A Guide to IMF Stress Testing Chapter 29. A Macro Stress Test Model of Credit Risk for the Brazilian Banking Sector in: A Guide to IMF Stress Testing](https://www.elibrary.imf.org/view/book/9781484368589/images/full-9781484368589_f0459-01.jpg)